Volume : 11, Issue : 11, November – 2024
Title:
A REVIEW OF PHYTOCHEMICALS WITH ANTIDEPRESSANT PROPERTIES
Authors :
Miss. Poojitha Gindi , Mrs. Y. Chandravadana , Mr. Dr. Venu Gopal
Abstract :
Depression is a prevalent and debilitating mental health disorder that affects millions globally, with significant impacts on individuals’ quality of life and well-being. While conventional antidepressants are widely used, there is growing interest in the potential of phytochemicals natural compounds found in plants as alternative treatments for depression. These plant-based compounds, including flavonoids, alkaloids, and terpenes, exhibit antidepressant-like properties through mechanisms such as neurotransmitter modulation, anti-inflammatory effects, and neuroprotection.
Phytochemicals like Hypericum perforatum (St. John’s Wort), Bacopa monnieri, and Rhodiola rosea have shown promise in reducing depressive symptoms with fewer side effects compared to synthetic drugs. Other plants, such as lavender, chamomile, and turmeric, contain bioactive substances that support mood regulation and stress reduction. Despite the potential benefits, challenges remain in standardizing plant extracts and ensuring their safety and efficacy through rigorous clinical studies. This article explores the role of various phytochemicals in managing depression, highlighting both their therapeutic advantages and limitations. The findings underscore the need for further research to validate these natural remedies and integrate them into holistic treatment approaches for depression, offering a complementary option alongside traditional therapies.
Cite This Article:
Please cite this article in press Poojitha Gindi et al., A Review Of Phytochemicals With Antidepressant Properties..,Indo Am. J. P. Sci, 2024; 11 (11).
Number of Downloads : 10
References:
1. Spitzer RL, Endicott J, Robins E (1975). “The development of diagnostic criteria in psychiatry” archived from the original on 14 December 2005. Retrieved 8 November 2008.
2. Gin Malhi S, John Mann J. Depression. Lancet 2018; 392:2299-12.
3. Woody CA, Ferrari AJ, Siskind DJ, Whiteford HA, Harris MG. A systematic review and meta-regression of the prevalence and incidence of perinatal depression. J Affect Discord. 2017; 219:86–92.
4. Schramm E, Klein DN, Elsaesser M, Furukawa TA, Domschke K. Review of dysthymia and persistent depressive disorder: history, correlates, and clinical implications. Lancet Psychiatry. 2020 Sep;7(9):801-812.
5. McIntyre RS, Berk M, Brietzke E, Goldstein BI, López-Jaramillo C, Kessing LV, Malhi GS, Nierenberg AA, Rosenblat JD, Majeed A, Vieta E, Vinberg M, Young AH, Mansur RB. Bipolar disorders. Lancet. 2020 Dec 05;396(10265):1841-1856.
6. Hutcherson TC, Cieri-Hutcherson NE, Gosciak MF. Brexanolone for postpartum depression. Am J Health Syst Pharm. 2020 Feb 19;77(5):336-345.
7. Fonte A, Coutinho B. Seasonal sensitivity and psychiatric morbidity: study about seasonal affective disorder. BMC Psychiatry. 2021 Jun 29;21(1):317.
8. Guze SB, Woodruff RAJr, ClaytonPJ. The significance of psychotic affective disorders. Arch Gen Psychiatry. 1975Sep;32(9):1147–50.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Second Edition. 2 ed. Washington, D.C.: American Psychiatric Press, Inc.; 1968.
10. Behl T, Rana T, Sehgal A, Sharma N, Albarrati A, Albratty M, Makeen HA, Najmi A, Verma R, Bungau SG. Prog Neuropsychopharmacology Biol Psychiatry. 2023 Apr 20; 123:110693. doi: 10.1016/j.pnpbp.2022.110693. Epub 2022 Dec 9. PMID: 36509251.
11. Lulu Cui, Shu Li, Major depressive disorder: hypothesis, mechanism, prevention and treatment 9,30;2024.
12. Fasipe O (2018). Neuropharmacological classification of antidepressant agents based on their mechanism of action.Neuropharmacological archives of medicine and health sciences.6(1):81.doi:10.4103/amhs.7-18.
13. Atanas G. Atanasov, Natural products in drug discovery: advances and opportunities.20,200-216(2021).
14. Dos Santos, linalool as a therapeutic and medicinal tool in depression treatment: a review current neuropharmacology 2022, pp 1073-1092.
15. Shih-Hang Lin, A medicinal herb, Melissa officinalis L. ameliorates depressive-like behavior of rats in the forced swimming test via regulating the serotonergic neurotransmitter. ethnopharmacology 2015,4-175.
16. Arshad Uddin Ahmed Syed, Assessment of anti-depressant activity of omega 3 fatty acids in rodents. pharmacology 2018,12-7.
17. Alessandro Cuomo s-Adenosylmethionine (SAMe) in major depressive disorder (MDD): a clinician-oriented systematic review.2020, 5-19.
18. Imran Kazmi, Anticonvulsant and depressant-like activity of ursolic acid stearoyl glucoside isolated from Lantana camara L. (verbanaceae). 2012,7-12.
19. Shivananjappa M, Joshi M. Aqueous extract of Tulsi (Ocimum sanctum) enhances endogenous antioxidant defenses of human hepatoma cell line (HepG2) J Herbs Spices Med Plants. 2012; 18:331–48.
20. K.G. LIoyd et al. Neuropsychopharmacol. Biol. Psychiat 1989.
21. Soo-Hyun Park, Antidepressant-like effect of chlorogenic acid isolated from Artemisia capillaris Thunb.2010,12-14.
22. Shrinivas K. Kulkarni, On the mechanism of antidepressant-like action of berberine chloride.2008,28-589.
23. Yuting Ke, Preventive and Therapeutic Effects of Astaxanthin on Depressive-Like Behaviors in High-Fat Diet and Streptozotocin-Treated Rats. neuropharmacology 2020,30-10.
24. Pablo Ferreira-Chamorro, Sulforaphane Inhibited the Nociceptive Responses, Anxiety- and Depressive-Like Behaviors Associated with Neuropathic Pain and Improved the Anti-allodynic Effects of Morphine in Mice. pharmacology 2018,20-9.
25. Reem N. El-Naga, Effects of indole-3-carbinol on clonidine-induced neurotoxicity in rats: Impact on oxidative stress, inflammation, apoptosis and monoamine levels. Pharmacology 2014,19-44.
26. Al Mamun, Evalution of CNS depressant and analgesic activities of the methanol extract of piper longum linn. leaves. pharmacy2011,27-2.
27. Solomon umukoro, Naringenin attenuates behavioral derangements induced by social defeat stress in mice via inhibition of acetylcholinesterase activity, oxidative stress and release of pro-inflammatory cytokines. neuropharmacology2018-105.
28. Carlo Tenore Coffee and Depression: A Short Review of Literature. current pharmaceutical design.2015,21.
29. Jagamohan Padhy, Antidepressant Effect of Acetyl-L-Carnitine and Bupropion against Experimental Animal Model. department of pharmacy 2024,30-16.
30. Alhasan Sabah Mansour, Assessment of Antidepressant Profile of Methanolic extract of Areca catechu using Mice as an experimental Model .2021,15-35.
31. Clare stevinson, A systematic review of safety of kava extract in the treatment of anxiety.2012,21-25.
32. H Dang, Y Chen, X Liu, Q Wang, Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression,2009.
33. Arthur Osol, A Physicochemical Study of Gentisic Acid.1952,6-41.
34. Padmaja Kalshetti, Antidepressant and Anti-Anxiety Effect of Ellagic Acid from Punica granatum L. Rind in Olfactory Bulbectomy Model in Rats.pharmacology.2015 31-32.
35. Bansal Sudha, Behavioral,biochemical and histopathological evalution of sinapic acid for antidepressant activity in mice and stressed mice.2023,2-16.
36. Xiaoyu Dong, Ferulic acid: An extraordinarily neuroprotective phenolic acid with anti-depressive properties. neurology,2022-105.
37. Maria c.olianas, inhibition of TNF-alpha induced neuronal apotosis by antidepressants acting through the lysophosphatidic acid receptor LPA1,2019-24.
38. Haroon khan, Current standing of plant derived flavonoids as an antidepressant.2018-119.
39. Haroon khan, Targeting BDNF modulation by plant glycosides as a novel therapeutic strategy in the treatment of depression.2018-196.
40. Mariana meckes, Terpenoids Isolated from Psidium guajava Hexane Extract with Depressant Activity on Central Nervous System.1996-10.
41. Muragundla anjaneulu, Antidepressant Activity of Quercetin, a Bioflavonoid, in Streptozotocin-Induced Diabetic Mice.2006-41.
42. Yingcong yua, the anti-depressant effects of a novel PDE4 inhibitor derived from resveratrol.2020-59.